Abstract
Much confusion arises in the field of agonist-effector supersensitivity phenomena due to the often encountered lack of discrimination between agonist disposition mechanisms functioning, in the system under study, as access barriers and as terminating mechanisms. Access barriers limit agonist approach to the receptor region and terminating mechanisms serve to remove agonist from the site of action. The assumption of a quantitative identity in these two functions is not often warranted and the effects inhibition of these processes have on the magnitude of effector responses and on their duration can differ strikingly, both qualitatively and quantitatively.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
